Code
|
Display
|
Definition
|
126513
|
Cetuximab ^89^Zr |
A Zr 89 Cetuximab PET Radiotracer. |
126755
|
RO5323441 ^89^Zr |
A Zr 89 RO5323441 PET Radiotracer. |
126514
|
J591 ^89^Zr |
A Zr 89 J591 PET Radiotracer. |
126756
|
RO542908 ^89^Zr |
A Zr 89 RO542908 PET Radiotracer. |
126515
|
cU36 ^89^Zr |
A Zr 89 cU36 PET Radiotracer. |
126757
|
RO6958948 ^18^F |
A PET radiotracer used for tau brain imaging.See Wong DF, Comley R, Kuwabara H, Rosenberg PB, Resnick SM, Ostrowitzki S, et al. First in-human PET study of 3 novel tau radiopharmaceuticals: [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948. J Nucl Med. 2018 May 4; doi:10.2967/jnumed.118.209916. |
126516
|
Bevacizumab ^89^Zr |
A Zr 89 Bevacizumab PET Radiotracer. |
126758
|
PSMA-1007 F^18^ |
A PET radiotracer targeting PMSA used for prostate cancer imaging.See Giesel FL, Hadaschik B, Cardinale J, Radtke J, Vinsensia M, Lehnert W, et al. F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients. Eur J Nucl Med Mol Imaging. 2017 Apr 1;44(4):678–88. doi:10.1007/s00259-016-3573-4. |
126517
|
cG250-F(ab')(2) ^89^Zr |
A Zr 89 cG250-F(ab')(2) PET Radiotracer. |
126759
|
PSMA-617 Ga^68^ |
A PET radiotracer targeting PMSA used for prostate cancer imaging.See Afshar-Oromieh A, Hetzheim H, Kratochwil C, Benesova M, Eder M, Neels OC, et al. The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions. J Nucl Med. 2015 Nov 1;56(11):1697–705. doi: 10.2967/jnumed.115.161299. |
126518
|
R1507 ^89^Zr |
A Zr 89 R1507 PET Radiotracer. |
126519
|
E4G10 ^89^Zr |
A Zr 89 E4G10 PET Radiotracer. |
126750
|
7E11 ^89^Zr |
A Zr 89 7E11 PET Radiotracer. |
126751
|
7D12 ^89^Zr |
A Zr 89 7D12 PET Radiotracer. |
126752
|
28H1 ^89^Zr |
A Zr 89 28H1 PET Radiotracer. |
126510
|
Monoclonal Antibody ^64^Cu |
A Cu 64 Monoclonal Antibody (mAb) PET Radiotracer. |
126511
|
Monoclonal Antibody ^89^Zr |
A Zr 89 Monoclonal Antibody (mAb) PET Radiotracer. |
126753
|
Nanocolloidal albumin ^89^Zr |
A Zr 89 nanocolloidal albumin PET Radiotracer.See Heuveling et al. Pilot Study on the Feasibility of PET/CT Lymphoscintigraphy with 89Zr-Nanocolloidal Albumin for Sentinel Node Identification in Oral Cancer Patients. J Nucl Med. 2013 Apr;54(4):585-9. doi:10.2967/jnumed.112.115188. http://jnm.snmjournals.org/content/54/4/585.long |
126754
|
Anti-B220 ^89^Zr |
A Zr 89 Anti-B220 PET Radiotracer. |
126512
|
Trastuzumab ^89^Zr |
A Zr 89 Trastuzumab PET Radiotracer. |
126502
|
T807 F^18^ |
A PHF-tau PET radiotracer. |
126503
|
Flubatine F^18^ |
A nicotinic α4β2 receptor (nAChR) PET radiotracer. |
126746
|
cMAb U36 ^89^Zr |
A Zr 89 cMAb U36 PET Radiotracer. |
126747
|
DN30 ^89^Zr |
A Zr 89 DN30 PET Radiotracer. |
126748
|
Fresolimumab ^89^Zr |
A Zr 89 Fresolimumab PET Radiotracer. |
126749
|
TRC105 ^89^Zr |
A Zr 89 TRC105 PET Radiotracer. |
126740
|
Margetuximab ^89^Zr |
A Zr 89 Margetuximab PET Radiotracer. |
126741
|
SAR3419 ^89^Zr |
A Zr 89 SAR3419 PET Radiotracer. |
126500
|
Pittsburgh compound B C^11^ |
A beta-amyloid PET radiotracer that is an analog of thioflavin T. |
126742
|
Ranibizumab ^89^Zr |
A Zr 89 Ranibizumab PET Radiotracer. |
126733
|
Roledumab ^89^Zr |
A Zr 89 Roledumab PET Radiotracer. |
126734
|
XmAb5574 ^89^Zr |
A Zr 89 XmAb5574 PET Radiotracer. |
126735
|
Brentuximab ^89^Zr |
A Zr 89 Brentuximab PET Radiotracer. |
126736
|
Panitumumab ^89^Zr |
A Zr 89 Panitumumab PET Radiotracer. |
126737
|
Rituximab ^89^Zr |
A Zr 89 Rituximab PET Radiotracer. |
126738
|
Mogamulizumab ^89^Zr |
A Zr 89 Mogamulizumab PET Radiotracer. |
126739
|
Ublituximab ^89^Zr |
A Zr 89 Ublituximab PET Radiotracer. |
126730
|
MEDI-551 ^89^Zr |
A Zr 89 MEDI-551 PET Radiotracer. |
126731
|
GA201 ^89^Zr |
A Zr 89 GA201 PET Radiotracer. |
126732
|
Ecromeximab ^89^Zr |
A Zr 89 Ecromeximab PET Radiotracer. |
126722
|
Benralizumab ^89^Zr |
A Zr 89 Benralizumab PET Radiotracer. |
126723
|
Ocaratuzumab ^89^Zr |
A Zr 89 Ocaratuzumab PET Radiotracer. |
126724
|
Glembatumumab vedotin ^89^Zr |
A Zr 89 Glembatumumab vedotin PET Radiotracer. |
126725
|
Pinatuzumab vedotin ^89^Zr |
A Zr 89 Pinatuzumab vedotin PET Radiotracer. |
126726
|
Polatuzumab vedotin ^89^Zr |
A Zr 89 Polatuzumab vedotin PET Radiotracer. |
126727
|
Blinatumomab ^89^Zr |
A Zr 89 Blinatumomab PET Radiotracer. |
126728
|
Pegdinetanib ^89^Zr |
A Zr 89 Pegdinetanib PET Radiotracer. |
126729
|
AGN-150998 ^89^Zr |
A Zr 89 AGN-150998 PET Radiotracer. |
126720
|
RO6931643 ^11^C |
A PET radiotracer used for tau brain imaging.See Wong DF, Comley R, Kuwabara H, Rosenberg PB, Resnick SM, Ostrowitzki S, et al. First in-human PET study of 3 novel tau radiopharmaceuticals: [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948. J Nucl Med. 2018 May 4; doi:10.2967/jnumed.118.209916. |
126721
|
Obinituzimab ^89^Zr |
A Zr 89 Obinituzimab PET Radiotracer. |
126719
|
RO6924963 ^11^C |
A PET radiotracer used for tau brain imaging.See Wong DF, Comley R, Kuwabara H, Rosenberg PB, Resnick SM, Ostrowitzki S, et al. First in-human PET study of 3 novel tau radiopharmaceuticals: [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948. J Nucl Med. 2018 May 4; doi:10.2967/jnumed.118.209916. |
126711
|
Glutamine F^18^ |
An F 18 Glutamine PET radiotracer. |
126713
|
2FA F^18^ |
An F 18 2FA PET radiotracer. |
126714
|
Nifene F^18^ |
An F 18 Nifene PET radiotracer. |
126715
|
CLR1404 I^124^ |
An I 124 cancer targeted phospholipid ether PET radiotracer. |
126716
|
CLR1404 I^131^ |
An I 131 cancer targeted phospholipid ether PET radiotracer. |
126718
|
Flurpiridaz F^18^ |
A PET radiotracer used for myocardial perfusion imaging.See Yu M, Nekolla SG, Schwaiger M, Robinson SP. The Next Generation of Cardiac Positron Emission Tomography Imaging Agents: Discovery of Flurpiridaz F-18 for Detection of Coronary Disease. Seminars in Nuclear Medicine. 2011 Jul;41(4):305-13. doi:10.1053/j.semnuclmed.2011.02.004See SNMMI. Flurpiridaz. |
126710
|
Glutamine C^14^ |
A C 14 Glutamine PET radiotracer. |
126709
|
Glutamine C^11^ |
A C 11 Glutamine PET radiotracer. |
126700
|
ATSM Cu^60^ |
A Cu 60 ATSM PET radiotracer. |
126701
|
ATSM Cu^61^ |
A Cu 61 ATSM PET radiotracer. |
126702
|
ATSM Cu^62^ |
A Cu 62 ATSM PET radiotracer. |
126703
|
Choline C^11^ |
A C 11 Choline PET radiotracer. |
126704
|
Fallypride C^11^ |
A C 11 Fallypride PET radiotracer. |
126705
|
Fallypride F^18^ |
An F 18 Fallypride PET radiotracer. |
126706
|
FLB 457 C^11^ |
A C 11 FLB 457 PET radiotracer. |
126707
|
Fluorotriopride F^18^ |
An F 18 Fluorotriopride PET radiotracer. |
126766
|
DPA-714 ^18^F |
An F18 translocator protein (TSPO) PET tracer.See Vicidomini C, Panico M, Greco A, Gargiulo S, Coda ARD, Zannetti A, et al. In vivo imaging and characterization of [18F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET. Nuclear Medicine and Biology. 2015 Mar 1;42(3):309–16. doi:10.1016/j.nucmedbio.2014.11.009 |
126760
|
Df-FK ^89^Zr |
A Zr 89 Df-FK peptide PET Radiotracer.See Jacobsen O et al. MicroPET Imaging of Integrin αvβ3 Expressing Tumors Using 89Zr-RGD Peptides. Mol Imaging Biol. 2011 Dec; 13(6): 1224-1233. doi:10.1007/s11307-010-0458-y. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137711/ |
126761
|
Df-FK-PEG(3) ^89^Zr |
A Zr 89 Df-FK-PEG(3) peptide PET Radiotracer.See Jacobsen O et al. MicroPET Imaging of Integrin αvβ3 Expressing Tumors Using 89Zr-RGD Peptides. Mol Imaging Biol. 2011 Dec; 13(6): 1224-1233. doi:10.1007/s11307-010-0458-y. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137711/ |
126762
|
Df-[FK](2) ^89^Zr |
A Zr 89 Df-[FK](2) peptide PET Radiotracer.See Jacobsen O et al. MicroPET Imaging of Integrin αvβ3 Expressing Tumors Using 89Zr-RGD Peptides. Mol Imaging Biol. 2011 Dec; 13(6): 1224-1233. doi:10.1007/s11307-010-0458-y. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137711/ |
126520
|
Df-CD45 ^89^Zr |
A Zr 89 Df-CD45 PET Radiotracer. |
126763
|
Df-[FK](2)-3PEG(4) ^89^Zr |
A Zr 89 Df-[FK](2)-3PEG(4) peptide PET Radiotracer.See Jacobsen O et al. MicroPET Imaging of Integrin αvβ3 Expressing Tumors Using 89Zr-RGD Peptides. Mol Imaging Biol. 2011 Dec; 13(6): 1224-1233. doi:10.1007/s11307-010-0458-y. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137711/ |
126765
|
DPA-713 ^11^C |
A C11 translocator protein (TSPO) PET tracer.See Endres CJ, Pomper MG, James M, Uzuner O, Hammoud DA, Watkins CC, et al. Initial Evaluation of 11C-DPA-713, a Novel TSPO PET Ligand, in Humans. J Nucl Med. 2009 Aug;50(8):1276–82. doi:10.2967/jnumed.109.062265http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883612/ |